Emerging evidence indicates that the podocyte epithelial-to-mesenchymal transition (EMT) has emerged as a potential pathway leading to proteinuria in DN [44], because of podocyte dysfunction caused by the loss of the podocyte-specific markers nephrin and podocin [44, 45]. The gene discussed is NPHS2; the disease is liver dysplastic nodule.